Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

The new rule is expected to extend the telemedicine flexibilities through the end of 2026 and will maintain the status quo while the DEA and the Department of Health and Human Services work toward a ...

Medicare Part B costs will rise in 2026. Here's what to expect, including higher prescription drug prices and payment changes ...

By Patrick Wingrove Dec 4 (Reuters) - Billionaire Mark Cuban has urged the Trump administration to waive the hundreds of ...

How much Novo Nordisk’s weight-loss drug Wegovy costs can depend on a lot of things, which makes it very hard for the average ...

Dec 8 (Reuters) - Mirum Pharmaceuticals said on Monday it will acquire Bluejay Therapeutics in a deal worth up to $820 ...

In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting ...

The Centers for Medicare & Medicaid Services extended a safety net to older Americans by announcing significant price ...

Mirum inks 620M deal to acquire Bluejay Therapeutics, adding brelovitug, a phase 3 hepatitis delta drug, to its liver disease pipeline.

Cuban attributes the US’ high drug prices to PBMs—often considered the “middlemen” within the pharma supply chain—arguing ...

Remicade, the brand name for infliximab, is an intravenous biologic therapy for conditions such as Crohn's disease, ...